ATE399173T1 - Pharmazeutische zubereitungen - Google Patents

Pharmazeutische zubereitungen

Info

Publication number
ATE399173T1
ATE399173T1 AT97913320T AT97913320T ATE399173T1 AT E399173 T1 ATE399173 T1 AT E399173T1 AT 97913320 T AT97913320 T AT 97913320T AT 97913320 T AT97913320 T AT 97913320T AT E399173 T1 ATE399173 T1 AT E399173T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparations
independently
phosphoenolpyruvate
alky
aralkyl
Prior art date
Application number
AT97913320T
Other languages
English (en)
Inventor
Albina Vladimirovna Dogadina
Igor Evgenyevich Gourevitch
Boris Iosifovich Ionine
Original Assignee
Itc Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Itc Res Ltd filed Critical Itc Res Ltd
Application granted granted Critical
Publication of ATE399173T1 publication Critical patent/ATE399173T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/664Amides of phosphorus acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/113Esters of phosphoric acids with unsaturated acyclic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2412Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of unsaturated acyclic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2454Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2462Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of unsaturated acyclic amines
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT97913320T 1996-11-21 1997-11-21 Pharmazeutische zubereitungen ATE399173T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9624188.0A GB9624188D0 (en) 1996-11-21 1996-11-21 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ATE399173T1 true ATE399173T1 (de) 2008-07-15

Family

ID=10803259

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97913320T ATE399173T1 (de) 1996-11-21 1997-11-21 Pharmazeutische zubereitungen

Country Status (10)

Country Link
US (1) US6184214B1 (de)
EP (1) EP0942915B1 (de)
JP (1) JP4135984B2 (de)
AT (1) ATE399173T1 (de)
AU (1) AU737679B2 (de)
DE (1) DE69738793D1 (de)
DK (1) DK0942915T3 (de)
ES (1) ES2309994T3 (de)
GB (1) GB9624188D0 (de)
WO (1) WO1998022479A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436997B1 (en) 1998-06-01 2002-08-20 Nitromed, Inc. Endogenous nitric oxide synthesis under conditions of low oxygen tension
US6277884B1 (en) 1998-06-01 2001-08-21 Nitromed, Inc. Treatment of sexual dysfunction with N-hydroxyguanidine compounds
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20080125400A1 (en) * 2006-11-27 2008-05-29 Christopher Speirs Use of phosphoenolpyruvate derivatives
CA3157761A1 (en) * 2019-11-10 2021-05-14 Pro-Al Medico-Technologies, Inc. Novel formulations and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3246M (fr) * 1964-02-06 1965-04-12 Pharmacodynamie Et Metabolisme Médicaments a base d'acide phospho-énol-pyruvique.
US3940458A (en) * 1972-02-29 1976-02-24 Mobil Oil Corporation 1-Carbamoyl vinyl phosphates
SE8200252L (sv) * 1982-01-18 1983-07-19 Pharmacia Ab Farmaceutisk komposition
US4874882A (en) * 1986-03-25 1989-10-17 Ube Industries, Ltd. Process for preparing monosodium phosphoenolpyruvate
JPH064656B2 (ja) * 1986-08-13 1994-01-19 宇部興産株式会社 ホスホエノ−ルピルビン酸モノナトリウム塩1水和物の製造方法
US4880786A (en) * 1987-01-14 1989-11-14 Ube Industries, Ltd. Additive solution for blood preservation and activation
US4826675A (en) 1988-02-17 1989-05-02 Colgate-Palmolive Company Anticalculus oral composition
JP2770175B2 (ja) * 1988-09-27 1998-06-25 科学技術振興事業団 腎臓の庇護液
RU2043358C1 (ru) 1992-11-24 1995-09-10 Игорь Евгеньевич Гуревич Способ получения фосфоенолпирувата
US5395822A (en) * 1993-09-20 1995-03-07 Izumi; Yukitoshi Use of pyruvate to prevent neuronal degeneration associated with ischemia
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production

Also Published As

Publication number Publication date
JP4135984B2 (ja) 2008-08-20
AU5062098A (en) 1998-06-10
DE69738793D1 (de) 2008-08-07
EP0942915B1 (de) 2008-06-25
DK0942915T3 (da) 2008-11-03
EP0942915A1 (de) 1999-09-22
AU737679B2 (en) 2001-08-30
GB9624188D0 (en) 1997-01-08
US6184214B1 (en) 2001-02-06
ES2309994T3 (es) 2008-12-16
JP2001506594A (ja) 2001-05-22
WO1998022479A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
AU549927B2 (en) 2-oxindole-1-carboxamide derivatives
DE69830504D1 (de) Antithrombotische mitteln
DE69831868D1 (en) Antithrombosemittel
TR199903278T2 (en) 2-Substit�te 4,5-Diaril imidazoller.
ATE72448T1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
EA199600104A1 (ru) Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты
TR199901674T2 (de)
AU689304B2 (en) Quinazoline derivative
SE9802206D0 (sv) Novel compounds
IE860222L (en) Imidazole derivatives.
DE69738793D1 (de) Pharmazeutische zubereitungen
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
RU94046387A (ru) Производные пиримидина, способ их получения, фармацевтическая композиция, ее применение и промежуточные продукты
DE69405999D1 (de) Pharmazeutisch wirksame enantiomere
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
TR199902820T2 (xx) Multisiklik eritromisin t�revleri.
TR200002012T2 (tr) İzopropil-metil [2-(3-n-propoksifenoksi)etil] amin' in yeni bir fosfat tuzu.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0942915

Country of ref document: EP

REN Ceased due to non-payment of the annual fee